Novant’s proposed purchase of CHS hospitals ‘irreversibly’ harms competition, FTC says
Antitrust regulators filed this week to block the deal, a move akin to trying to stop a “ball that’s already rolling downhill,” one expert said.
UnitedHealth CFO John Rex to replace Dirk McMahon as president
McMahon announced earlier this year that he’d be retiring from the healthcare behemoth in April. Rex will be stepping up as president, though there’s no word on who will assume McMahon’s chief operating officer role.
Biden administration finalizes rule cracking down on short-term plans
Democrat lawmakers and patient advocacy groups cheered the final rule for protecting patients from the skimpy plans, while free-market advocates slammed it as limiting coverage options for consumers.
Inside CVS Health’s push to transform customer experience
The transformation, led by Deloitte Digital, focused on increasing customer feedback to identify pervasive issues and closing the loop on customer inquiries.
Walgreens posts $6B loss on waning VillageMD value; ups clinic closures
The retail pharmacy chain has closed 140 VillageMD locations to date to cut costs, blowing past its previous goal of 60 closures.
New federal health IT strategy increases focus on public health, AI
The draft plan builds on its predecessor, which the health IT agency said drove “significant progress” in the use and exchange of electronic health information.
CMS streamlines Medicaid, CHIP renewal and enrollment in final rule
The rule is the “most robust and meaningful” regulation streamlining Medicaid eligibility since the Affordable Care Act was implemented a decade ago, one lawyer said.
Ascension to divest three hospitals in northern Michigan
The deal comes as Ascension works to improve its financials and focus on expanded ambulatory and telehealth offerings.
Healthcare companies expand perks to recruit talent: report
The increase stands in contrast to other industries, which have cut back on extra offerings.
Medicare’s GLP-1 spending is skyrocketing, even without weight loss coverage: KFF
Gross Medicare spending on the pricey drugs rose from $57 million in 2018 to $5.7 billion in 2022, according to a new analysis from the health policy group.